Date/Time: This will be an ongoing 3-month cycle, with smaller groups meeting offline at their convenience
Who is this event intended for? Members of PSI
What is the benefit of attending? Participants will have the opportunity to; Network with colleagues from the industry; Discuss and practice learnings from a wide range of books; and (if participating as a facilitator), an opportunity to lead and chair discussions.
The next book we are reading is "Dare to Lead" by Brené Brown. Based on research conducted with leaders, change makers and culture shifters, this book shows how to put those ideas to "dare greatly, rise strong and brave the wilderness" into practice so we can set up and lead.
Contrary to the title, this is not your typical leadership book but it aims to help on your journey of personal-empowerment. It asks the question: What is courage actually and can it be learned, or do we have to be born with it? This book is fit for every career stage, form junior statisticians to the senior leadership team.
We are also looking for facilitators who will be leading the discussion groups. Facilitators will be provided guidance on how to run the group discussions and there will be a Q&A session at the beginning for any questions that may arise. Make sure to indicate on the registration form if you are interested!
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
